Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 3153

Salt Lake City/Sandy, UT 84070

Study Summary:

We are currently conducting a 24-week treatment, double blind, study to evaluate the effectiveness of the study GnrH antagonist oral medication for the reduction of pain and endometriosis symptoms.

A 150 mg dosage tablet, a 250 mg dosage tablet and placebo are used.

Women randomized to placebo are automatically rolled over to study drug treatment at 12 weeks.

Participants have a 33% chance of receiving placebo, but then only for half of the study treatment duration.

Qualified Participants Must:

• Be 18 to 49 years of age
• Have a surgical diagnosis of Endometriosis within the past 8 years from study start and be able to provide the study center with a copy of their last surgical report
• Have an intact uterus and both ovaries
• Be able to use condoms and spermicide for contraception during study (if S.A.)
• Have monthly menses approximately 28 +/- 5 days apart
• Be willing to wash out of hormonal birth control pills after signing consent
• Not have had Lupron, Danazol, or DepoProvera treatment in the past 3-6 months
• Other qualifications apply

Qualified Participants May Receive:

Study related physical exams, TVUs, lab-work, DEXA scans, study medication and up to $75.00 per completed visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.